U.K. MHRA Awards Tern Therapeutics Innovation Passport for TTX-381 to Accelerate Gene Therapy for the Treatment of the Ocular Manifestations of CLN2 Disease
U.K. MHRA awards Tern Therapeutics Innovation Passport for TTX-381 Tern
Find out more